Reports

Industry Research Reports

Parenteral Excipients- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Parenteral Excipients- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Pharma & Healthcare

Published Date: 2026-04-28

Pages: 130 Pages

Report ld: 5778839

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Parenteral Excipients Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

5.3%

marketSize

Market Size,2032

USD 1,534

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 1,125 million
Market Forecast in 2032(Value)
US$ 1,534 million
CAGR
5.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Parenteral Excipients was estimated to be worth US$ 1067 million in 2025 and is projected to reach US$ 1534 million, growing at a CAGR of 5.3% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Parenteral Excipients cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Parenteral excipients for injection are inactive ingredients used in injections, infusions, and lyophilized formulations. They primarily function to solubilize, stabilize, buffer, adjust tonicity, provide antioxidant protection, and protect the active ingredient, while meeting requirements for high purity, low endotoxin levels, and good injection safety.

Upstream suppliers mainly include pharmaceutical-grade sugars, amino acids, surfactants, buffer salts, chelating agents, antioxidants, solvents, aseptic packaging materials, and high-purity raw material suppliers. Downstream applications primarily target chemical injections, biopharmaceuticals, vaccines, liposomes, long-acting formulations, lyophilized powder injections, and CDMOs.

The global market price for parenteral excipients for injection is $7,511 per ton, with annual sales of approximately 142,000 tons and a global annual production capacity of approximately 180,000-200,000 tons. The industry profit margin is 15%.

The future global market for parenteral excipients for injection will move towards higher purity, higher functionality, and regulatory-driven upgrades. With the continued expansion of biologics, vaccines, complex injectable formulations, and high-concentration formulations, the market demand for excipients that solubilize, stabilize proteins/nucleic acids, control particulate matter and impurities, and improve compatibility and long-term storage performance will significantly increase. Simultaneously, regulatory agencies and pharmacopoeias are imposing stricter requirements on the quality attributes, impurity profiles, aseptic assurance, and specific application standards of injectable excipients, driving the supply chain towards greater consistency and traceability. On the other hand, multifunctional excipients, pre-formulated systems, and specialized excipients better suited for lipid nanoparticles, sustained-release injections, and biologics will become important directions.

This report provides a comprehensive view of the global market for Parenteral Excipients, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Parenteral Excipients market size, estimations, and forecasts are presented in terms of sales volume (K Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Parenteral Excipients.

MARKET SEGMENTATION

By Company

  • Merck
  • Ashland
  • Roquette
  • Croda Pharma
  • BASF
  • Evonik
  • Seppic
  • Lubrizol
  • Pfanstiehl

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Solubilizers
  • Bulker
  • Preservatives
  • Solvents
  • Others

Segment by Application

  • Precision Medicine
  • Biopharmaceuticals
  • Others

Segment by Category

  • Natural Source Excipients
  • Semi-Synthetic Excipients
  • Synthetic Excipients
  • Bio-Derived Excipients

Segment by Division

  • Excipients for Injection
  • Excipients for Infusion
  • Excipients for Lyophilized Powder for Injection
  • Excipients for Emulsions/Suspensions
  • Excipients For Liposomes/Lnps
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

marn_i1

Chapter 2: Provides a detailed analysis of the Parenteral Excipients manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

marn_i1

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 5: Presents Parenteral Excipients sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

marn_i1

Chapter 6: Presents Parenteral Excipients sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

marn_i1

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

marn_i1

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Parenteral Excipients Product Introduction

1.2 Global Parenteral Excipients Market Size Forecast

1.2.1 Global Parenteral Excipients Sales Value (2021–2032)

1.2.2 Global Parenteral Excipients Sales Volume (2021–2032)

1.2.3 Global Parenteral Excipients Sales Price (2021–2032)

1.3 Parenteral Excipients Market Trends & Drivers

1.3.1 Parenteral Excipients Industry Trends

1.3.2 Parenteral Excipients Market Drivers & Opportunities

1.3.3 Parenteral Excipients Market Challenges

1.3.4 Parenteral Excipients Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Parenteral Excipients Players Revenue Ranking (2025)

2.2 Global Parenteral Excipients Revenue by Company (2021–2026)

2.3 Global Parenteral Excipients Sales Volume Ranking of Players (2025)

2.4 Global Parenteral Excipients Sales Volume by Company (2021–2026)

2.5 Global Parenteral Excipients Average Price by Company (2021–2026)

2.6 Key Manufacturers Parenteral Excipients Manufacturing Base and Headquarters

2.7 Key Manufacturers Parenteral Excipients Product Offerings

2.8 Key Manufacturers Start of Mass Production of Parenteral Excipients

2.9 Parenteral Excipients Market Competitive Analysis

2.9.1 Parenteral Excipients Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Parenteral Excipients Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Parenteral Excipients revenue, 2025

2.10 Mergers & Acquisitions and Expansion

muLu

3 Segmentation Parenteral Excipients Market Classification

3.1 Introduction by Type

3.1.1 Solubilizers

3.1.2 Bulker

3.1.3 Preservatives

3.1.4 Solvents

3.1.5 Others

3.1.6 Global Parenteral Excipients Sales Value by Type

3.1.6.1 Global Parenteral Excipients Sales Value by Type (2021 vs 2025 vs 2032)

3.1.6.2 Global Parenteral Excipients Sales Value, by Type (2021–2032)

3.1.6.3 Global Parenteral Excipients Sales Value, by Type (%), 2021–2032

3.1.7 Global Parenteral Excipients Sales Volume by Type

3.1.7.1 Global Parenteral Excipients Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.7.2 Global Parenteral Excipients Sales Volume, by Type (2021–2032)

3.1.7.3 Global Parenteral Excipients Sales Volume, by Type (%), 2021–2032

3.1.8 Global Parenteral Excipients Average Price by Type (2021–2032)

3.2 Introduction by Source

3.2.1 Natural Source Excipients

3.2.2 Semi-Synthetic Excipients

3.2.3 Synthetic Excipients

3.2.4 Bio-Derived Excipients

3.2.5 Global Parenteral Excipients Sales Value by Source

3.2.5.1 Global Parenteral Excipients Sales Value by Source (2021 vs 2025 vs 2032)

3.2.5.2 Global Parenteral Excipients Sales Value, by Source (2021–2032)

3.2.5.3 Global Parenteral Excipients Sales Value, by Source (%), 2021–2032

3.2.6 Global Parenteral Excipients Sales Volume by Source

3.2.6.1 Global Parenteral Excipients Sales Volume by Source (2021 vs 2025 vs 2032)

3.2.6.2 Global Parenteral Excipients Sales Volume, by Source (2021–2032)

3.2.6.3 Global Parenteral Excipients Sales Volume, by Source (%), 2021–2032

3.2.7 Global Parenteral Excipients Average Price by Source (2021–2032)

3.3 Introduction by Dosage Form

3.3.1 Excipients for Injection

3.3.2 Excipients for Infusion

3.3.3 Excipients for Lyophilized Powder for Injection

3.3.4 Excipients for Emulsions/Suspensions

3.3.5 Excipients For Liposomes/Lnps

3.3.6 Others

3.3.7 Global Parenteral Excipients Sales Value by Dosage Form

3.3.7.1 Global Parenteral Excipients Sales Value by Dosage Form (2021 vs 2025 vs 2032)

3.3.7.2 Global Parenteral Excipients Sales Value, by Dosage Form (2021–2032)

3.3.7.3 Global Parenteral Excipients Sales Value, by Dosage Form (%), 2021–2032

3.3.8 Global Parenteral Excipients Sales Volume by Dosage Form

3.3.8.1 Global Parenteral Excipients Sales Volume by Dosage Form (2021 vs 2025 vs 2032)

3.3.8.2 Global Parenteral Excipients Sales Volume, by Dosage Form (2021–2032)

3.3.8.3 Global Parenteral Excipients Sales Volume, by Dosage Form (%), 2021–2032

3.3.9 Global Parenteral Excipients Average Price by Dosage Form (2021–2032)

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Precision Medicine

4.1.2 Biopharmaceuticals

4.1.3 Others

4.2 Global Parenteral Excipients Sales Value by Application

4.2.1 Global Parenteral Excipients Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Parenteral Excipients Sales Value, by Application (2021–2032)

4.2.3 Global Parenteral Excipients Sales Value, by Application (%), 2021–2032

4.3 Global Parenteral Excipients Sales Volume by Application

4.3.1 Global Parenteral Excipients Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Parenteral Excipients Sales Volume, by Application (2021–2032)

4.3.3 Global Parenteral Excipients Sales Volume, by Application (%), 2021–2032

4.4 Global Parenteral Excipients Average Price by Application (2021–2032)

muLu

5 Segmentation by Region

5.1 Global Parenteral Excipients Sales Value by Region

5.1.1 Global Parenteral Excipients Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Parenteral Excipients Sales Value by Region (2021–2026)

5.1.3 Global Parenteral Excipients Sales Value by Region (2027–2032)

5.1.4 Global Parenteral Excipients Sales Value by Region (%), 2021–2032

5.2 Global Parenteral Excipients Sales Volume by Region

5.2.1 Global Parenteral Excipients Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Parenteral Excipients Sales Volume by Region (2021–2026)

5.2.3 Global Parenteral Excipients Sales Volume by Region (2027–2032)

5.2.4 Global Parenteral Excipients Sales Volume by Region (%), 2021–2032

5.3 Global Parenteral Excipients Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Parenteral Excipients Sales Value, 2021–2032

5.4.2 North America Parenteral Excipients Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Parenteral Excipients Sales Value, 2021–2032

5.5.2 Europe Parenteral Excipients Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Parenteral Excipients Sales Value, 2021–2032

5.6.2 Asia Pacific Parenteral Excipients Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Parenteral Excipients Sales Value, 2021–2032

5.7.2 South America Parenteral Excipients Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Parenteral Excipients Sales Value, 2021–2032

5.8.2 Middle East & Africa Parenteral Excipients Sales Value by Country (%), 2025 vs 2032

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Parenteral Excipients Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Parenteral Excipients Sales Value and Sales Volume

6.2.1 Key Countries/Regions Parenteral Excipients Sales Value, 2021–2032

6.2.2 Key Countries/Regions Parenteral Excipients Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Parenteral Excipients Sales Value, 2021–2032

6.3.2 United States Parenteral Excipients Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Parenteral Excipients Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Parenteral Excipients Sales Value, 2021–2032

6.4.2 Europe Parenteral Excipients Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Parenteral Excipients Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Parenteral Excipients Sales Value, 2021–2032

6.5.2 China Parenteral Excipients Sales Value by Type (%), 2025 vs 2032

6.5.3 China Parenteral Excipients Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Parenteral Excipients Sales Value, 2021–2032

6.6.2 Japan Parenteral Excipients Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Parenteral Excipients Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Parenteral Excipients Sales Value, 2021–2032

6.7.2 South Korea Parenteral Excipients Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Parenteral Excipients Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Parenteral Excipients Sales Value, 2021–2032

6.8.2 Southeast Asia Parenteral Excipients Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Parenteral Excipients Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Parenteral Excipients Sales Value, 2021–2032

6.9.2 India Parenteral Excipients Sales Value by Type (%), 2025 vs 2032

6.9.3 India Parenteral Excipients Sales Value by Application, 2025 vs 2032

muLu

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Merck Parenteral Excipients Product Offerings

7.1.5 Merck Recent Developments

7.2 Ashland

7.2.1 Ashland Company Information

7.2.2 Ashland Introduction and Business Overview

7.2.3 Ashland Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Ashland Parenteral Excipients Product Offerings

7.2.5 Ashland Recent Developments

7.3 Roquette

7.3.1 Roquette Company Information

7.3.2 Roquette Introduction and Business Overview

7.3.3 Roquette Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Roquette Parenteral Excipients Product Offerings

7.3.5 Roquette Recent Developments

7.4 Croda Pharma

7.4.1 Croda Pharma Company Information

7.4.2 Croda Pharma Introduction and Business Overview

7.4.3 Croda Pharma Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Croda Pharma Parenteral Excipients Product Offerings

7.4.5 Croda Pharma Recent Developments

7.5 BASF

7.5.1 BASF Company Information

7.5.2 BASF Introduction and Business Overview

7.5.3 BASF Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 BASF Parenteral Excipients Product Offerings

7.5.5 BASF Recent Developments

7.6 Evonik

7.6.1 Evonik Company Information

7.6.2 Evonik Introduction and Business Overview

7.6.3 Evonik Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 Evonik Parenteral Excipients Product Offerings

7.6.5 Evonik Recent Developments

7.7 Seppic

7.7.1 Seppic Company Information

7.7.2 Seppic Introduction and Business Overview

7.7.3 Seppic Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 Seppic Parenteral Excipients Product Offerings

7.7.5 Seppic Recent Developments

7.8 Lubrizol

7.8.1 Lubrizol Company Information

7.8.2 Lubrizol Introduction and Business Overview

7.8.3 Lubrizol Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 Lubrizol Parenteral Excipients Product Offerings

7.8.5 Lubrizol Recent Developments

7.9 Pfanstiehl

7.9.1 Pfanstiehl Company Information

7.9.2 Pfanstiehl Introduction and Business Overview

7.9.3 Pfanstiehl Parenteral Excipients Sales, Revenue, Price and Gross Margin (2021–2026)

7.9.4 Pfanstiehl Parenteral Excipients Product Offerings

7.9.5 Pfanstiehl Recent Developments

muLu

8 Industry Chain Analysis

8.1 Parenteral Excipients Industrial Chain

8.2 Parenteral Excipients Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Parenteral Excipients Sales Model

8.5.2 Sales Channels

8.5.3 Parenteral Excipients Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Parenteral Excipients Market Trends
Table 2. Parenteral Excipients Market Drivers & Opportunities
Table 3. Parenteral Excipients Market Challenges
Table 4. Parenteral Excipients Market Restraints
Table 5. Global Parenteral Excipients Revenue by Company (US$ Million), 2021–2026
Table 6. Global Parenteral Excipients Revenue Market Share by Company (2021–2026)
Table 7. Global Parenteral Excipients Sales Volume by Company (K Tons), 2021–2026
Table 8. Global Parenteral Excipients Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Parenteral Excipients Price by Company (US$/Ton), 2021–2026
Table 10. Key Manufacturers Parenteral Excipients Manufacturing Base and Headquarters
Table 11. Key Manufacturers Parenteral Excipients Product Type
Table 12. Key Manufacturers Start of Mass Production of Parenteral Excipients
Table 13. Global Parenteral Excipients Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Parenteral Excipients revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Parenteral Excipients Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Parenteral Excipients Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Parenteral Excipients Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Parenteral Excipients Sales Market Share in Value by Type (2021–2026)
Table 20. Global Parenteral Excipients Sales Market Share in Value by Type (2027–2032)
Table 21. Global Parenteral Excipients Sales Volume by Type: 2021 vs 2025 vs 2032 (K Tons)
Table 22. Global Parenteral Excipients Sales Volume by Type (K Tons), 2021–2026
Table 23. Global Parenteral Excipients Sales Volume by Type (K Tons), 2027–2032
Table 24. Global Parenteral Excipients Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Parenteral Excipients Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Parenteral Excipients Price by Type (US$/Ton), 2021–2026
Table 27. Global Parenteral Excipients Price by Type (US$/Ton), 2027–2032
Table 28. Global Parenteral Excipients Sales Value by Source: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Parenteral Excipients Sales Value by Source (US$ Million), 2021–2026
Table 30. Global Parenteral Excipients Sales Value by Source (US$ Million), 2027–2032
Table 31. Global Parenteral Excipients Sales Market Share in Value by Source (2021–2026)
Table 32. Global Parenteral Excipients Sales Market Share in Value by Source (2027–2032)
Table 33. Global Parenteral Excipients Sales Volume by Source: 2021 vs 2025 vs 2032 (K Tons)
Table 34. Global Parenteral Excipients Sales Volume by Source (K Tons), 2021–2026
Table 35. Global Parenteral Excipients Sales Volume by Source (K Tons), 2027–2032
Table 36. Global Parenteral Excipients Sales Market Share in Volume by Source (2021–2026)
Table 37. Global Parenteral Excipients Sales Market Share in Volume by Source (2027–2032)
Table 38. Global Parenteral Excipients Price by Source (US$/Ton), 2021–2026
Table 39. Global Parenteral Excipients Price by Source (US$/Ton), 2027–2032
Table 40. Global Parenteral Excipients Sales Value by Dosage Form: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Global Parenteral Excipients Sales Value by Dosage Form (US$ Million), 2021–2026
Table 42. Global Parenteral Excipients Sales Value by Dosage Form (US$ Million), 2027–2032
Table 43. Global Parenteral Excipients Sales Market Share in Value by Dosage Form (2021–2026)
Table 44. Global Parenteral Excipients Sales Market Share in Value by Dosage Form (2027–2032)
Table 45. Global Parenteral Excipients Sales Volume by Dosage Form: 2021 vs 2025 vs 2032 (K Tons)
Table 46. Global Parenteral Excipients Sales Volume by Dosage Form (K Tons), 2021–2026
Table 47. Global Parenteral Excipients Sales Volume by Dosage Form (K Tons), 2027–2032
Table 48. Global Parenteral Excipients Sales Market Share in Volume by Dosage Form (2021–2026)
Table 49. Global Parenteral Excipients Sales Market Share in Volume by Dosage Form (2027–2032)
Table 50. Global Parenteral Excipients Price by Dosage Form (US$/Ton), 2021–2026
Table 51. Global Parenteral Excipients Price by Dosage Form (US$/Ton), 2027–2032
Table 52. Global Parenteral Excipients Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 53. Global Parenteral Excipients Sales Value by Application (US$ Million), 2021–2026
Table 54. Global Parenteral Excipients Sales Value by Application (US$ Million), 2027–2032
Table 55. Global Parenteral Excipients Sales Market Share in Value by Application (2021–2026)
Table 56. Global Parenteral Excipients Sales Market Share in Value by Application (2027–2032)
Table 57. Global Parenteral Excipients Sales Volume by Application: 2021 vs 2025 vs 2032 (K Tons)
Table 58. Global Parenteral Excipients Sales Volume by Application (K Tons), 2021–2026
Table 59. Global Parenteral Excipients Sales Volume by Application (K Tons), 2027–2032
Table 60. Global Parenteral Excipients Sales Market Share in Volume by Application (2021–2026)
Table 61. Global Parenteral Excipients Sales Market Share in Volume by Application (2027–2032)
Table 62. Global Parenteral Excipients Price by Application (US$/Ton), 2021–2026
Table 63. Global Parenteral Excipients Price by Application (US$/Ton), 2027–2032
Table 64. Global Parenteral Excipients Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 65. Global Parenteral Excipients Sales Value by Region (US$ Million), 2021–2026
Table 66. Global Parenteral Excipients Sales Value by Region (US$ Million), 2027–2032
Table 67. Global Parenteral Excipients Sales Value by Region (%), 2021–2026
Table 68. Global Parenteral Excipients Sales Value by Region (%), 2027–2032
Table 69. Global Parenteral Excipients Sales Volume by Region (K Tons): 2021 vs 2025 vs 2032
Table 70. Global Parenteral Excipients Sales Volume by Region (K Tons), 2021–2026
Table 71. Global Parenteral Excipients Sales Volume by Region (K Tons), 2027–2032
Table 72. Global Parenteral Excipients Sales Volume by Region (%), 2021–2026
Table 73. Global Parenteral Excipients Sales Volume by Region (%), 2027–2032
Table 74. Global Parenteral Excipients Average Price by Region (US$/Ton), 2021–2026
Table 75. Global Parenteral Excipients Average Price by Region (US$/Ton), 2027–2032
Table 76. Key Countries/Regions Parenteral Excipients Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 77. Key Countries/Regions Parenteral Excipients Sales Value, (US$ Million), 2021–2026
Table 78. Key Countries/Regions Parenteral Excipients Sales Value, (US$ Million), 2027–2032
Table 79. Key Countries/Regions Parenteral Excipients Sales Volume, (K Tons), 2021–2026
Table 80. Key Countries/Regions Parenteral Excipients Sales Volume, (K Tons), 2027–2032
Table 81. Merck Company Information
Table 82. Merck Introduction and Business Overview
Table 83. Merck Parenteral Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 84. Merck Parenteral Excipients Product Offerings
Table 85. Merck Recent Developments
Table 86. Ashland Company Information
Table 87. Ashland Introduction and Business Overview
Table 88. Ashland Parenteral Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 89. Ashland Parenteral Excipients Product Offerings
Table 90. Ashland Recent Developments
Table 91. Roquette Company Information
Table 92. Roquette Introduction and Business Overview
Table 93. Roquette Parenteral Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 94. Roquette Parenteral Excipients Product Offerings
Table 95. Roquette Recent Developments
Table 96. Croda Pharma Company Information
Table 97. Croda Pharma Introduction and Business Overview
Table 98. Croda Pharma Parenteral Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 99. Croda Pharma Parenteral Excipients Product Offerings
Table 100. Croda Pharma Recent Developments
Table 101. BASF Company Information
Table 102. BASF Introduction and Business Overview
Table 103. BASF Parenteral Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 104. BASF Parenteral Excipients Product Offerings
Table 105. BASF Recent Developments
Table 106. Evonik Company Information
Table 107. Evonik Introduction and Business Overview
Table 108. Evonik Parenteral Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 109. Evonik Parenteral Excipients Product Offerings
Table 110. Evonik Recent Developments
Table 111. Seppic Company Information
Table 112. Seppic Introduction and Business Overview
Table 113. Seppic Parenteral Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 114. Seppic Parenteral Excipients Product Offerings
Table 115. Seppic Recent Developments
Table 116. Lubrizol Company Information
Table 117. Lubrizol Introduction and Business Overview
Table 118. Lubrizol Parenteral Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 119. Lubrizol Parenteral Excipients Product Offerings
Table 120. Lubrizol Recent Developments
Table 121. Pfanstiehl Company Information
Table 122. Pfanstiehl Introduction and Business Overview
Table 123. Pfanstiehl Parenteral Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 124. Pfanstiehl Parenteral Excipients Product Offerings
Table 125. Pfanstiehl Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Key Suppliers of Raw Materials Lists
Table 128. Parenteral Excipients Downstream Customers
Table 129. Parenteral Excipients Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Parenteral Excipients Product Picture
Figure 2. Global Parenteral Excipients Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 4. Global Parenteral Excipients Sales Volume (K Tons), 2021–2032
Figure 5. Global Parenteral Excipients Sales Price (US$/Ton), 2021–2032
Figure 6. Parenteral Excipients Report Years Considered
Figure 7. Global Parenteral Excipients Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Parenteral Excipients Sales Volume Ranking of Players (K Tons), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Parenteral Excipients Revenue in 2025
Figure 10. Parenteral Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Solubilizers Picture
Figure 12. Bulker Picture
Figure 13. Preservatives Picture
Figure 14. Solvents Picture
Figure 15. Others Picture
Figure 16. Global Parenteral Excipients Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Parenteral Excipients Sales Value Market Share by Type, 2025 & 2032
Figure 18. Global Parenteral Excipients Sales Volume by Type (K Tons), 2021 vs 2025 vs 2032
Figure 19. Global Parenteral Excipients Sales Volume Market Share by Type, 2025 & 2032
Figure 20. Global Parenteral Excipients Price by Type (US$/Ton), 2021–2032
Figure 21. Natural Source Excipients Picture
Figure 22. Semi-Synthetic Excipients Picture
Figure 23. Synthetic Excipients Picture
Figure 24. Bio-Derived Excipients Picture
Figure 25. Global Parenteral Excipients Sales Value by Source (US$ Million), 2021 vs 2025 vs 2032
Figure 26. Global Parenteral Excipients Sales Value Market Share by Source, 2025 & 2032
Figure 27. Global Parenteral Excipients Sales Volume by Source (K Tons), 2021 vs 2025 vs 2032
Figure 28. Global Parenteral Excipients Sales Volume Market Share by Source, 2025 & 2032
Figure 29. Global Parenteral Excipients Price by Source (US$/Ton), 2021–2032
Figure 30. Excipients for Injection Picture
Figure 31. Excipients for Infusion Picture
Figure 32. Excipients for Lyophilized Powder for Injection Picture
Figure 33. Excipients for Emulsions/Suspensions Picture
Figure 34. Excipients For Liposomes/Lnps Picture
Figure 35. Others Picture
Figure 36. Global Parenteral Excipients Sales Value by Dosage Form (US$ Million), 2021 vs 2025 vs 2032
Figure 37. Global Parenteral Excipients Sales Value Market Share by Dosage Form, 2025 & 2032
Figure 38. Global Parenteral Excipients Sales Volume by Dosage Form (K Tons), 2021 vs 2025 vs 2032
Figure 39. Global Parenteral Excipients Sales Volume Market Share by Dosage Form, 2025 & 2032
Figure 40. Global Parenteral Excipients Price by Dosage Form (US$/Ton), 2021–2032
Figure 41. Product Picture of Precision Medicine
Figure 42. Product Picture of Biopharmaceuticals
Figure 43. Product Picture of Others
Figure 44. Global Parenteral Excipients Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 45. Global Parenteral Excipients Sales Value Market Share by Application, 2025 & 2032
Figure 46. Global Parenteral Excipients Sales Volume by Application (K Tons), 2021 vs 2025 vs 2032
Figure 47. Global Parenteral Excipients Sales Volume Market Share by Application, 2025 & 2032
Figure 48. Global Parenteral Excipients Price by Application (US$/Ton), 2021–2032
Figure 49. North America Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 50. North America Parenteral Excipients Sales Value by Country (%), 2025 vs 2032
Figure 51. Europe Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 52. Europe Parenteral Excipients Sales Value by Country (%), 2025 vs 2032
Figure 53. Asia Pacific Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 54. Asia Pacific Parenteral Excipients Sales Value by Region (%), 2025 vs 2032
Figure 55. South America Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 56. South America Parenteral Excipients Sales Value by Country (%), 2025 vs 2032
Figure 57. Middle East & Africa Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 58. Middle East & Africa Parenteral Excipients Sales Value by Country (%), 2025 vs 2032
Figure 59. Key Countries/Regions Parenteral Excipients Sales Value (%), 2021–2032
Figure 60. Key Countries/Regions Parenteral Excipients Sales Volume (%), 2021–2032
Figure 61. United States Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 62. United States Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
Figure 63. United States Parenteral Excipients Sales Value by Application (%), 2025 vs 2032
Figure 64. Europe Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 65. Europe Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
Figure 66. Europe Parenteral Excipients Sales Value by Application (%), 2025 vs 2032
Figure 67. China Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 68. China Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
Figure 69. China Parenteral Excipients Sales Value by Application (%), 2025 vs 2032
Figure 70. Japan Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 71. Japan Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
Figure 72. Japan Parenteral Excipients Sales Value by Application (%), 2025 vs 2032
Figure 73. South Korea Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 74. South Korea Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
Figure 75. South Korea Parenteral Excipients Sales Value by Application (%), 2025 vs 2032
Figure 76. Southeast Asia Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 77. Southeast Asia Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
Figure 78. Southeast Asia Parenteral Excipients Sales Value by Application (%), 2025 vs 2032
Figure 79. India Parenteral Excipients Sales Value (US$ Million), 2021–2032
Figure 80. India Parenteral Excipients Sales Value by Type (%), 2025 vs 2032
Figure 81. India Parenteral Excipients Sales Value by Application (%), 2025 vs 2032
Figure 82. Parenteral Excipients Industrial Chain
Figure 83. Parenteral Excipients Manufacturing Cost Structure
Figure 84. Channels of Distribution (Direct Sales, and Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Parenteral Excipients market?zhanKai
The top companies in the global Parenteral Excipients market are Merck、Ashland、Roquette.
What is the annual compound growth rate of the global Parenteral Excipients market size from 2026 to 2032?shouQi
What was the global market size of Parenteral Excipients in 2026?shouQi
What was the global market size of Parenteral Excipients in 2032?shouQi
Which region is expected to have the highest market share?shouQi
den_biaoTiZhungShi

Related Reports

Parenteral Excipients- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Pharma & Healthcare

Published Date: 2026-04-28

Pages: 130 Pages

Report ld: 5778839

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now